Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07503067 · ClinicalTrials.gov registry record
Identifying Substance Use Consequences
A clinical trial, sponsored by Mclean Hospital.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07503067: Recruiting study, sponsored by Mclean Hospital.
NCT07503067 is a clinical trial that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07503067 is actively recruiting participants, sponsored by Mclean Hospital.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The goal of this study is to develop a new tool for measuring substance use disorder treatment outcome. We will start by interviewing people and gathering advisory groups to develop the items for this new tool.
Primary Outcome
thematic analysis of qualitative interviews to extract common themes
Interventions
- OTHER none, there is no intervention in this study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-02-10 |
| Est. Completion | 2027-07-31 |
What NCT07503067 shows while recruiting
NCT07503067 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which none, there is no intervention in this study is the first listed.
NCT07503067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07503067 about?
NCT07503067 is a clinical study titled "Identifying Substance Use Consequences". The goal of this study is to develop a new tool for measuring substance use disorder treatment outcome. We will start by interviewing people and gathering advisory groups to develop the items for this new tool.
What is the current status of trial NCT07503067?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-02-10. Estimated completion is 2027-07-31.
What interventions are being tested in trial NCT07503067?
The interventions under investigation include: none, there is no intervention in this study (OTHER).
Who is sponsoring clinical trial NCT07503067?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI